Low predictive power of clinical features for relapse prediction after antidepressant discontinuation in a naturalistic setting.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
01 07 2022
01 07 2022
Historique:
received:
07
03
2022
accepted:
30
05
2022
entrez:
1
7
2022
pubmed:
2
7
2022
medline:
8
7
2022
Statut:
epublish
Résumé
The risk of relapse after antidepressant medication (ADM) discontinuation is high. Predictors of relapse could guide clinical decision-making, but are yet to be established. We assessed demographic and clinical variables in a longitudinal observational study before antidepressant discontinuation. State-dependent variables were re-assessed either after discontinuation or before discontinuation after a waiting period. Relapse was assessed during 6 months after discontinuation. We applied logistic general linear models in combination with least absolute shrinkage and selection operator and elastic nets to avoid overfitting in order to identify predictors of relapse and estimated their generalisability using cross-validation. The final sample included 104 patients (age: 34.86 (11.1), 77% female) and 57 healthy controls (age: 34.12 (10.6), 70% female). 36% of the patients experienced a relapse. Treatment by a general practitioner increased the risk of relapse. Although within-sample statistical analyses suggested reasonable sensitivity and specificity, out-of-sample prediction of relapse was at chance level. Residual symptoms increased with discontinuation, but did not relate to relapse. Demographic and standard clinical variables appear to carry little predictive power and therefore are of limited use for patients and clinicians in guiding clinical decision-making.
Identifiants
pubmed: 35778458
doi: 10.1038/s41598-022-13893-9
pii: 10.1038/s41598-022-13893-9
pmc: PMC9249776
doi:
Substances chimiques
Antidepressive Agents
0
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
11171Subventions
Organisme : Swiss National Science Foundation
ID : 320030L_153449/1
Pays : Switzerland
Informations de copyright
© 2022. The Author(s).
Références
JAMA Psychiatry. 2014 Oct;71(10):1157-64
pubmed: 25142196
Am J Psychiatry. 2006 Jan;163(1):101-8
pubmed: 16390896
Psychol Med. 1996 May;26(3):477-86
pubmed: 8733206
World J Biol Psychiatry. 2013 Jul;14(5):334-85
pubmed: 23879318
J Psychiatr Res. 2006 Feb;40(1):59-69
pubmed: 16243357
Psychol Med. 2010 Jan;40(1):41-50
pubmed: 19460188
Neuropsychiatr Dis Treat. 2011;7(Suppl 1):3-7
pubmed: 21750622
Aust N Z J Psychiatry. 2010 Aug;44(8):697-705
pubmed: 20636190
Arch Gen Psychiatry. 2005 Apr;62(4):417-22
pubmed: 15809409
J Affect Disord. 2009 Mar;113(3):263-71
pubmed: 18625521
World Psychiatry. 2013 Feb;12(1):44-52
pubmed: 23471801
Am J Psychiatry. 2006 Nov;163(11):1905-17
pubmed: 17074942
Harv Rev Psychiatry. 1998 Mar-Apr;5(6):293-306
pubmed: 9559348
Arch Gen Psychiatry. 2011 Dec;68(12):1227-37
pubmed: 22147842
Neurosci Biobehav Rev. 2015 Oct;57:328-49
pubmed: 26254595
Front Psychol. 2011 Jul 07;2:159
pubmed: 21779273
Acta Psychiatr Scand. 2010 Sep;122(3):184-91
pubmed: 20003092
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Lancet. 2003 Feb 22;361(9358):653-61
pubmed: 12606176
J Clin Psychiatry. 2004 Mar;65(3):373-8
pubmed: 15096077
Arch Gen Psychiatry. 1998 Apr;55(4):334-43
pubmed: 9554429
Arch Gen Psychiatry. 1988 Aug;45(8):742-7
pubmed: 3395203
Lancet Psychiatry. 2016 Mar;3(3):243-50
pubmed: 26803397
Arch Gen Psychiatry. 1991 Sep;48(9):851-5
pubmed: 1929776
Psychol Rev. 2005 Apr;112(2):417-45
pubmed: 15783292
Psychol Med. 2010 Aug;40(8):1367-77
pubmed: 19863842
Psychol Methods. 2011 Mar;16(1):17-33
pubmed: 21381817
J Clin Psychiatry. 2000 Jul;61(7):518-24
pubmed: 10937611
Sci Rep. 2020 Dec 18;10(1):22346
pubmed: 33339879
Clin Psychol Rev. 2007 Dec;27(8):959-85
pubmed: 17448579
Transl Psychiatry. 2018 Nov 5;8(1):241
pubmed: 30397196
JAMA Psychiatry. 2016 Apr;73(4):346-53
pubmed: 26934026
Nat Neurosci. 2016 Mar;19(3):404-13
pubmed: 26906507
Prim Care Companion J Clin Psychiatry. 2007;9(2):91-9
pubmed: 17607330
JAMA. 1984 Aug 10;252(6):788-92
pubmed: 6748178
Arch Gen Psychiatry. 1987 Mar;44(3):259-64
pubmed: 3548638
Psychol Med. 2017 Feb;47(3):426-437
pubmed: 27786144
JAMA. 1983 Dec 23-30;250(24):3299-304
pubmed: 6645026
Lancet Psychiatry. 2017 Mar;4(3):230-237
pubmed: 28189575
JAMA Psychiatry. 2020 May 1;77(5):513-522
pubmed: 32074255
J Clin Psychiatry. 2008 Sep;69(9):1423-36
pubmed: 19193343
Neuropsychopharmacology. 2004 May;29(5):1012-8
pubmed: 14997172
Compr Psychiatry. 2011 Mar-Apr;52(2):151-5
pubmed: 21295221
Proc Natl Acad Sci U S A. 2015 Nov 10;112(45):13892-7
pubmed: 26504198
J Affect Disord. 2021 Jan 1;278:218-225
pubmed: 32971314
Int J Neuropsychopharmacol. 2015 Jul 07;19(2):
pubmed: 26152228
JAMA. 2003 Jun 18;289(23):3095-105
pubmed: 12813115
Psychol Rev. 2011 Oct;118(4):655-74
pubmed: 21895384